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Abstract 
Purpose: To investigate the impact of different cylinder positions on dosimetry of critical structures in patients with 
endometrial carcinoma undergoing three-dimensional image-based vaginal cuff brachytherapy (VCB). 
Material and methods: We delivered VCB at a dose of 4 Gy to a depth of 5 mm in the vaginal cuff of 15 patients 
using three different cylinder positions (neutral [N], parallel [P], and angled [A]) according to the longitudinal axis of 
the patient. We analyzed the dose-volume distribution and volumetric variability of the rectum and bladder. We con-
verted the total doses to equivalent doses in 2 Gy (EQD2) using a linear-quadratic model (a/b = 3 Gy). 
Results: The mean rectum volume for the N, P, and A positions was 68.2 ± 22.7 cc, 79.3 ± 33.7 cc, and 74.2 ± 29.6 cc, 
respectively. The mean rectum volume for the P position was significantly larger than that for the N position (p = 0.03). 
Relative to the N position, the A position resulted in a lower total EQD2 in the highest irradiated 2 cc (D2cc; p = 0.001), 
1 cc (D1cc; p = 0.004), and 0.1 cc (D0.1cc; p = 0.047) of the rectum. Similarly, the P position resulted in a lower EQD2 in the 
D2cc (p = 0.018) and D1cc (p = 0.024) of the rectum relative to the N position. In the bladder, the P position resulted in 
a higher EQD2 in the D2cc relative to the N position (p = 0.02). There was no dosimetric difference between the P and 
A positions in either the rectum or the bladder.
Conclusions: Vaginal cuff brachytherapy in the P and A positions is significantly superior to that in the N position 
in terms of rectum dosimetry. The bladder dose in the N position is considerably lower than that in the other positions. 
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Purpose 
Endometrial carcinoma (EC) is the most common gy-
necological malignancy in developed countries, with the 
highest incidence occurring in the sixth and seventh de-
cades of life [1]. Surgery is the first step of treatment, fol-
lowed by external beam radiotherapy (EBRT) with vagi-
nal cuff brachytherapy (VCB) in selected cases [2,3]. After 
surgery, VCB may be used either as the sole adjuvant mo-
dality in patients with intermediate-risk EC or as a com-
plementary component with EBRT in high-risk patients 
[4]. Vaginal cuff brachytherapy has a steep dose fall-off, 
which restricts critical organ doses while applying a high 
and localized radiation dose to the vaginal cuff.
The most common site of recurrence in patients with 
EC is the vaginal cuff [5,6]. That recurrence pattern may 
be one of the major reasons to use VCB as a localized ad-
juvant treatment directed to the vaginal cuff in patients 
with EC. In the PORTEC-2 trial, patients with stage I or 
IIA disease, including high-intermediate risk factors, 
were randomized and treated with either EBRT or VCB. 
In that study, there was no significant difference in local 
recurrence between the two treatments; however, the pa-
tients treated with VCB had less gastrointestinal toxicity 
and better quality of life [7,8]. During VCB application, 
the anterior rectal wall, bladder, and sigmoid are located 
near the area that is exposed to high-dose radiation. The 
high radiation dose to those organs may cause certain tox-
icities following the treatment. Therefore, it is important 
to consider all factors related to the dosimetry of critical 
organs and the target volume. Although numerous stud-
ies have investigated the effects of indication [4,9], treat-
ment time [10], size [4,11], and style [12] of the cylinder, 
filling of the bladder and rectum [4,13,14], dose fraction-
ation, and prescription [4,15], the impact of the cylinder 
position has received little study. 
The purpose of this study was to analyze wheth-
er changes in the cylinder position impact the radiation 
dose delivered to critical structures in patients undergo-
ing three-dimensional (3D) image-based high-dose-rate 
brachytherapy. 
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Material and methods 
Patients 
In our study, we enrolled 15 patients with endome-
trial adenocarcinoma, undergoing post-surgery VCB and 
EBRT. External beam radiotherapy was delivered to pel-
vic lymphatics and the primary tumor bed at a prescribed 
dose of 45 Gy in 25 fractions using 3D conformal radio-
therapy. This study was approved by the Baskent Univer-
sity Institutional Review Board (Project no: KA16/362), 
and supported by the Baskent University Research Fund. 
The treatment protocol used in our department was 
described elsewhere [13]. Briefly, all patients had a thor-
ough gynecologic examination to assess wound healing 
and to evaluate vaginal size before the placement of the 
VCB cylinder. The largest computed tomography (CT) – 
compatible vaginal cylinder was chosen for each patient 
to achieve the best contact between the vaginal mucosa 
and the surface of the cylinder. Lubricated condoms were 
used to facilitate the application and cleaning. In our rou-
tine practice, CT planning in the parallel (P) position is 
performed for the first fraction of application, and the 
same plan is used for the subsequent fractions of VCB. 
Catheterization of the bladder and rectal enema are not 
routinely used. The length of the cylinder protruding out-
side the vagina is noted to provide uniformity for subse-
quent insertions. 
Treatment planning 
Three consecutive CT images were obtained for each 
patient by setting the cylinder in neutral (N), parallel (P), 
and angled (A) positions according to the cranial-caudal 
axis of the patient (Figure 1). In the N position, the cylin-
der was inserted into the vagina in a manner consistent 
with the patient’s anatomy, and no effort was made to 
correct the natural insertion angle of the cylinder. In the 
P position, the cylinder was tilted downwards, so that it 
was as parallel as possible to the cranial-caudal axis of 
the patient. In the A position, the tip of the cylinder was 
moved upwards from the patient’s axial plane, keeping 
the caudal end of the cylinder stationary. After each ma-
neuver, the cylinder was immobilized with a universal 
applicator clamping device (Varian Medical Systems, 
Inc., Palo Alto, CA, USA), which was located under-
neath the patient. A CT scan with 2.5 mm slice thickness 
through the pelvis was used for treatment planning. Ev-
ery patient was prompted to empty the bladder before 
the initial CT process. 
All CT slices were transferred to a 3D treatment plan-
ning system (BrachyVision™ Eclipse; Varian Medical 
Systems, Palo Alto, CA, USA). A dose of 12 Gy in three 
fractions was applied to a depth of 5 mm from the cylin-
der surface to treat the entire vaginal cuff. The vaginal 
length was measured on CT images, and the apical two-
thirds of the vaginal cylinder were activated, except in 
patients with a short vaginal length, in accordance with 
our institutional practice. As a result, a total of 45 CT 
scans, including three cylinder positions for each patient, 
were analyzed. 
Organs at risk 
In order to minimize inter-observer variability, a single 
physician contoured the clinical target volume (CTV), blad-
der, and rectum of each patient. The contour of the CTV 
was determined by expanding the upper two segments of 
the cylinder by 5 mm in all directions from the cylinder 
surface. The outer wall of the rectum and the entire blad-
der were delineated as critical organs. To accommodate 
the volumetric rectal variations relative to the position of 
the cylinder, the rectum was contoured in a manner sug-
gested in a previous study [16]. Thus, the rectum was de-
lineated from 1 cm above the cylinder apex to 1.5 cm below 
the last activated cylinder segment. We also recorded the 
volumes of the rectum and bladder to assess the volumet-
ric variations due to the different cylinder positions. For 
the critical organs, we calculated the minimum dose to the 
highest irradiated 2 cc (D2cc), 1 cc (D1cc), and 0.1 cc (D0.1cc) of 
the rectum, and to the D2cc and D0.1cc of the bladder in each 
application. The dose statistics for the rectum are shown 
in Table 1. We converted the physical dose distributions 
in Table 1, in terms of the VCB (for one fraction) and the 
previous EBRT (for 25 fractions), to biologically equivalent 
Fig. 1. The 4 Gy isodose area (red) according to the vaginal cylinder in the (A) neutral, (B) parallel, and (C) angled positions in 
a representative patient 
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doses {BED; BED = n.d. [1 + d/(a/b)]} to account for the 
dose per fraction as given in fractions of 2 Gy {EQD2; EQD2 
= BED/[1 + 2/(a/b)]} using a linear quadratic model with 
a/b = 3 Gy [17]. Additionally, we estimated an approxi-
mate EQD2 VCB value for the three fractions of VCB, based 
on the doses shown in Table 1.
Statistical analysis 
We analyzed the data using SPSS version 20 (SPSS, 
Chicago, IL, USA). We determined the volumes of all 
specified organs at risk and compared the dose-volume 
histograms for each of the cylinder positions. We used 
the Wilcoxon matched-pairs test to determine significant 
differences in volumes and doses between the cylinder 
positions. We considered differences statistically signif-
icant at p < 0.05. 
Results 
We analyzed a total of 45 CT scans from 15 patients 
with cylinders in the N, P, and A positions. The cylin-
der diameter was 3.5 cm for all of the patients. The mean 
rectal volume for the P, A, and N positions was 79.3 ± 
33.7 cc, 74.2 ± 29.6 cc, and 68.2 ± 22.7 cc, respectively. The 
mean rectum volume for the P position was significantly 
larger than that for the N position (p = 0.03). There was no 
significant difference in bladder volume among the three 
cylinder positions. 
The D2cc, D0.1cc, and D1cc of the rectum in the three po-
sitions are shown in Table 2. The BEDEBRT and EQD2EBRT 
were 72 Gy and 43.2 Gy, respectively. The sum of the 
two modalities (EQD2 EBRT and EQD2 VCB) in the rectal 
D2cc, D0.1cc, and D1cc is listed for three fractions of VCB in 
Table 3. The total EQD2 in the D2cc (p = 0.001), D0.1cc 
Table 1. Dose levels to the rectum according to the cylinder positions in vaginal cuff brachytherapy (VCB) and 
equivalent dose calculated in 2 Gy (EQD2) of external beam radiotherapy
Cases EQD2 EBRT
(1.8 Gy × 25 fx)
VCB 
(fx)
D2cc (fx/Gy) D0.1cc (fx/Gy) D1cc (fx/Gy)
N P A N P A N  P A
1 43.2 3 4.9 4.5 4.5 6.4 6.3 5.6 5.2 4.8 5.1
2 43.2 3 5.2 4.5 4.5 6.5 6.2 5.4 5.5 4.8 4.9
3 43.2 3 5.3 4.8 3.7 6.2 5.9 4.6 5.8 5.1 4.0
4 43.2 3 5.6 3.2 4.4 7.2 3.9 5.5 6.2 3.5 4.7
5 43.2 3 4.9 4.8 5.6 6.3 5.7 8.3 5.2 5.1 6.0
6 43.2 3 5.4 4.9 4.2 6.4 6.3 5.1 5.4 5.5 4.4
7 43.2 3 5.2 5.2 4.7 5.3 5.6 5.6 5.4 5.4 4.9
8 43.2 3 5.1 4.7 4.1 6.6 5.4 4.9 5.4 4.9 4.4
9 43.2 3 4.0 3.6 3.8 4.9 4.1 4.5 4.3 3.8 4.0
10 43.2 3 6.0 5.1 5.0 8.4 6.1 5.5 7.2 5.5 5.3
11 43.2 3 5.3 4.7 4.9 6.3 5.9 5.9 5.6 4.9 5.2
12 43.2 3 5.0 4.4 4.2 6.3 5.1 5.1 5.2 4.6 4.5
13 43.2 3 3.8 5.2 3.8 5.1 8.1 5.1 4.2 5.8 4.2
14 43.2 3 6.4 4.7 4.6 9.2 8.8 5.6 7.5 5.7 5.1
15 43.2 3 4.1 4.1 4.1 4.9 4.6 5.1 4.3 3.6 4.4
EQD2 – equivalent dose calculated in 2 Gy, Gy – gray, fx –fractions, D 2cc, 0.1cc, 1cc – the minimum dose to the most irradiated of 2 cc, 0.1 cc, and 1 cc of organ, 
VCB – vaginal cuff brachytherapy, N, P, A – neutral, parallel, and angled cylinder positions, respectively 
Table 2. Mean rectum dose statistics according to the vaginal cylinder positions for one fraction of brachy-
therapy 
Rectal dose 
statistics
Cylinder position p
N (Gy ± SD) P (Gy ± SD) A (Gy ± SD) N vs. P N vs. A P vs. A
D2cc 5.1 ± 0.7 4.5 ± 0.6 4.4 ± 0.5 0.013 0.001 0.6
D0.1cc 6.4 ± 1.2 5.9 ± 1.3 5.5 ± 0.9 0.15 0.001 0.3
D1cc 5.5 ± 0.9 4.9 ± 0.7 4.7 ± 0.6 0.03 0.005 0.5
N – neutral, P – parallel, A – angled, D2cc, 0.1cc, 1cc – the minimum dose to the most irradiated of 2 cc, 0.1 cc, and 1 cc of organ, Gy – gray 
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(p = 0.047), and D1cc (p = 0.004) of the rectum for the A po-
sition was significantly lower than the corresponding 
values for the N position. Similarly, the EQD2 in the D2cc 
(p = 0.018) and D1cc (p = 0.024) of the rectum for the 
P position was significantly lower than the corresponding 
values for the N position. The differences in the dose sta-
tistics maintained their significance when we estimated 
the EQD2 for three fractions of VCB (Table 3). Despite the 
significant differences between the N and P positions and 
between the N and A positions, there was no difference 
in terms of rectal doses between the P and A positions 
(Figure 2). 
Regarding the bladder, the EQD2 in the D2cc for the 
P position was significantly higher than that for the N po-
sition (2.2 ± 0.5 vs. 2.0 ± 0.4; p = 0.02). 
Discussion 
Although some brachytherapy studies have focused 
on the association between the angles or positions of the 
vaginal cylinder and rectal doses in patients with EC, 
there is little data showing the impact of the vaginal cyl-
inder position on the critical organ doses in the context 
of EQD2. Our analysis demonstrated that the N position 
was associated with unfavorable EQD2 values compared 
with the P and A positions in terms of the rectal D2cc, 
D0.1cc, and D1cc. Additionally, manipulating the cylinder 
in a more angular manner, moving the cylinder from the 
P position to the A position, did not make any difference 
in the rectal doses. Conversely, despite the disadvantages 
of the N position in terms of the rectal doses, the bladder 
doses for the N position were lower than those for the 
P and A positions. However, the bladder was not the 
main topic in our study. 
The relationship between the dose and the effect in 
radiotherapy is linear-quadratic rather than linear. There-
fore, the cumulative effect of different treatment methods 
cannot be identified by adding the doses linearly [18]. 
The various fractions of VCB and EBRT used in clinical 
practice can be considered together by converting the dif-
ferent units into a single unit, a concept known as EQD2, 
which allows clinicians to compare different dose rates 
and dose fractions. 
Regarding the rectal dose statistics, the D2cc (EQD2) 
is the most established parameter as a predictor of rectal 
toxicity in studies of intracavitary brachytherapy (ICB) 
and interstitial brachytherapy (IB) [19,20,21,22]. In a pre-
vious study, Georg et al. assessed the D2cc in patients with 
cervical carcinoma who were treated with EBRT and ICB 
in terms of Grade 1-4 rectal toxicities on the Late Effects 
on Normal Tissues-Subjective, Objective, Management, 
and Analytic (LENT-SOMA) scale and found that 72 Gy 
was more relevant than 63 Gy [21]. Chopra et al. [20] sug-
gested that limiting the D2cc exposure to < 55 Gy was as-
Table 3. Total* rectal doses according to cylinder position 
Dose-volume 
parameters
Cylinder position p
N (Gy ± SD) P (Gy ± SD) A (Gy ± SD) N vs. P N vs. A P vs. A
D2cc 67.3 ± 5.5 63.4 ± 4.8 62.1 ± 3.8 0.028 0.002 0.34
D0.1cc 79.3 ± 12 73.1 ± 12.3 70.5 ± 8.4 0.08 0.028 0.49
D1cc 70.9 ± 8.4 66.1 ± 5.6 64.5 ± 4.3 0.043 0.007 0.35
*Total dose is provided in equivalent dose calculated in 2 Gy (EQD2) and EQD2 is calculated as EQD2 EBRT + EQD2 VCB. The EQD2 VCB was calculated based on the  
D2cc, 0.1cc, 1cc values presented in Table 1. The EQD2 EBRT was calculated for the total EBRT fractions 
EBRT – external beam radiotherapy, VCB – vaginal cuff brachytherapy, Gy – gray, N – neutral, P – parallel, A – angled, D2cc, 0.1cc, 1cc – the minimum dose to the most 
irradiated of 2 cc, 0.1 cc, and 1 cc of organ  
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sociated with less Grade 2 rectal toxicity in patients with 
recurrent cervical carcinoma. In addition, Sakata et al. [23] 
found that patients with maximal rectal EQD2 > 60 Gy 
experienced more rectal toxicity. Supporting the results 
of Sakata et al., another report showed that a cumulative 
dose of > 65 Gy (EQD2) was associated with more Grade 
2 LENT-SOMA rectal morbidities [24]. 
Our study demonstrates only a dosimetric pattern 
and lacks toxicity data; however, the rectal dose sta-
tistics, shown in Table 3, may offer some foresight into 
possible rectal toxicities in the period following treat-
ment. For the total EQD2 VCB, we used the initial rectal 
dose statistics in the first fraction of VCB for two subse-
quent imaginary fractions. Significant variation in rectal 
dose should not be expected among the three fractions 
of VCB when differences in cylinder position or angle 
are excluded, considering the common clinical practice 
of performing the fractions of VCB based on the initial 
planning CT [25]. 
According to our results, the mean values of the dose 
statistics (D2cc, D0.1cc, and D1cc) in terms of EQD2 were all 
significantly higher for the N position than for the P and 
A positions (Table 3). Despite the lack of a symptomatic 
assessment of rectal toxicity in our study, the mean EQD2 
for the D2cc (67.3 ± 5.5), D0.1cc (79.3 ± 12), and D1cc (70.9 ± 
8.4) of the rectum in our study appeared to be safer than 
those observed by Georg et al. (72 ± 6, 88 ± 10, and 76 ± 7, 
respectively) [21]. 
There have been some reports of the advantages of 3D 
VCB compared with two-dimensional (2D) VCB [26,27]. 
In contrast to the dose specification process of 2D plan-
ning, which is based on the pelvic bone, 3D VCB uses vol-
umetric treatment planning, and hence has more precise 
target coverage, which is critical for certain patients. For 
instance, while patients who undergo VCB without EBRT 
are expected to experience limited rectum and bladder 
toxicities, the VCB-related dose may become important 
in patients who receive an EBRT dose of 45-50.4 Gy prior 
to VCB. Additionally, further techniques have been uti-
lized to minimize the critical organ doses, including mod-
ifications of the bladder [13,28] or rectal filling [29], the 
position of the patient on the couch [30], or the geometry 
of the vaginal cylinder [31]. 
In a previous study, Hoskin et al. moved the vaginal 
cylinder from the N position to the P position in 30 pa-
tients with EC who were treated with VCB and report-
ed an average rectal dose reduction of 1.3 Gy for a pre-
scribed dose of 5.5 Gy [31]. Our results differ from those 
of Hoskin et al. in some instances. First, we performed 
a dosimetric analysis of three different positions of the 
vaginal cylinder according to the cranial-caudal plane of 
the patient. Second, we used CT images, which are more 
reliable to assess the variability of doses and critical-or-
gan delineations, among different set-up positions com-
pared with the radiographs used by Hoskin et al. Third, 
our report is more comparable to other reports in terms of 
cumulative doses and possible side effects because of our 
use of EQD2 in our analyses. However, our results agree 
with those of Hoskin et al. in that the rectal doses in our 
patients diminished as the tip of the cylinder was moved 
upward from the axial plane of the patient (p < 0.05 for 
D1cc and D2cc in the A position) at the cost of increasing 
the mean bladder dose. 
Another previous dosimetric study lends indirect 
support to our results. Lati et al. [30] investigated the in-
fluence of two different patient positions without correct-
ing the cylinder angle in the vagina. The rectal dose in pa-
tients positioned with a leg extended was lower than that 
in patients in the lithotomy position (D2cc, 4.24 Gy vs. 5.14 
Gy; p = 0.003). The lithotomy position may be considered 
as the opposite of our A position, because the vaginal cuff 
in the lithotomy position is moved posteriorly, approach-
ing the rectum, and consequently, the rectum is exposed 
to higher radiation doses because of its proximity to the 
vaginal cylinder in the cuff. 
Our volumetric analyses showed that the rectal vol-
ume for the P position was significantly larger than that 
for the N position (79.3 ± 33.7 cc vs. 68.2 ± 22.7 cc; p = 
0.03). The movement of rectal contents and gas through 
the hollow rectum during the application in different 
cylinder positions may be the major reason for the vol-
umetric variation. Additionally, CT may have limited 
sensitivity to delineate the rectal wall, especially for the 
distal part of the organ. 
Our study has several limitations. First, our patient 
cohort was small, and all of the patients were treated at 
a single institution. Second, the angled application of the 
cylinder was performed arbitrarily without a fixed an-
gle, which might cause some angular variability. Third, 
although the P and A positions had advantages relative 
to the N position in terms of the rectal radiation dose, we 
did not attempt to determine the optimal cylinder angles. 
Conclusions 
We examined the dosimetric influence of three differ-
ent cylinder positions for the application of VCB in terms 
of EQD2 in patients with EC. Our results demonstrate 
that VCB in the P and A positions results in significant-
ly lower rectal radiation doses compared with that in the 
N position, at the expense of higher bladder doses. De-
spite the similar rectal dosimetry of the P and A posi-
tions, the bladder dose may increase when the cylinder 
is moved upward from the patient’s axial plane. Further 
studies, including toxicity analysis in larger cohorts, may 
be more demonstrative of the optimal cylinder position 
for the treatment of the vaginal cuff. 
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